ADMA
ADMA Biologics Inc Q3 2026 Earnings Preview: What Analysts Expect on November 04, 2026
ADMA Biologics is expected to report Q3 2026 consensus revenue of $139.8 million (+4.16% YoY) and EPS of $0.19 (+18.75% YoY), with its stock currently trading...
